Will all 5 to 11 year olds get a Covid vaccine? How vaccinations could be used to stop UK school disruption

Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement.

The Covid vaccine has currently only been approved for vulnerable children aged five to 11

The UK Covid-19vaccination rollout is likely to be extended to all children aged five to 11, a health expert has claimed.

Under current rules, only those in a clinical risk group, or who are a household contact of someone who is immunosuppressed, are being offered the jab.

Hide Ad
Hide Ad

The Joint Committee on Vaccination and Immunisation (JCVI) recommended vaccinating vulnerable children in December, but are yet to approve the jab for everyone in this age group.

The JCVI recommended vaccinating vulnerable children in December (Photo: Getty Images)The JCVI recommended vaccinating vulnerable children in December (Photo: Getty Images)
The JCVI recommended vaccinating vulnerable children in December (Photo: Getty Images) | Getty Images

However, with high coronavirus case numbers currently causing staff shortages across various public sectors, including schools, due to people isolating, it is thought that the vaccine rollout may be extended to help minimise disruption to young people’s education.

What’s been said?

Professor Russell Viner, professor of child and adolescent health at University College London, has suggested that the “balance of risks” point towards vaccinating all five to 11 year olds when the impact of school disruption from Covid-19 is taken into account.

Prof Viner told the i: “Five to 11s are probably the group least affected by Covid disease.

Hide Ad
Hide Ad

The thing about Covid is it’s got the most extraordinary age risk profile… to be honest, five to 11 is the healthiest time of our life.

“It’s the time when we’re least likely to die or get sick from almost anything, and that is true of Covid.

“However, I expect and I would like [the Government] to include educational disruption and mental health issues in the decision, which is what happened with teenagers.

“I think it’s a very marginal medical decision, but if you include those broader issues, I think given the extremely promising safety profile in children – I don’t want to second-guess the JCVI – but I think the balance of risks is towards vaccination.”

Hide Ad
Hide Ad

Is the vaccine safe for children?

The Medicines and Healthcare products Regulatory Agency (MHRA) recommended two 10 micrograms doses of the Pfizer vaccine at an interval of eight weeks between the first and second doses for vulnerable five to 11 year olds.

The formulation has been specially designed for this age group and is given at a lower dose compared to that used in children aged 12 and over.

Professor Viner added that current data suggests the risk of myocarditis – an extremely rare side effect of some Covid-19 vaccines which causes inflammation of the heart – is far lower in primary-school-age children compared to older teens.

But he warned that vaccinating all youngsters could be difficult, as little ones care “much more likely to get distressed”.

Hide Ad
Hide Ad

Additionally, as the jabs for five to 11-year-olds contain a lower amount of the vaccine, the NHS would have to ensure a steady supply of the paediatric dose to centres and train staff in administering it.

He said: “There’s a whole lot of complexities about vaccinating children that I’m sure that the NHS is thinking through, but this won’t be easy.

“It won’t be as if the JCVI announces it and a month later we have all our children vaccinated.”

How will a decision on vaccinating more children be made?

The JCVI has said further advice on extending the Covid-19 vaccination rollout to all five to 11 year olds will be issued “in due course following consideration of additional data.”

Hide Ad
Hide Ad

The JCVI will first consider the following data before a decision is made:

  • updated estimates of the proportion of children aged five to 11 years who have already been infected
  • the level of protection afforded against Covid-19 disease due to the Omicron variant from previous coronavirus infection
  • post-marketing adverse event reporting data from the international use of the Pfizer Covid-19 vaccine in those aged five to 11 years
  • considerations from the Department of Health and Social Care (DHSC) and other government departments on the potential educational impacts (both benefits and disbenefits) of Covid-19 vaccination in those aged five to 11 years

A message from the editor:

Thank you for reading. NationalWorld is a new national news brand, produced by a team of journalists, editors, video producers and designers who live and work across the UK. Find out more about who’s who in the team, and our editorial values. We want to start a community among our readers, so please follow us on Facebook, Twitter and Instagram, and keep the conversation going. You can also sign up to our newsletters and get a curated selection of our best reads to your inbox every day.

Comment Guidelines

National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.